Clinical trial
Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT00115518 · Heidelberg University, Other · Completed
Key facts
| NCT number | NCT00115518 |
|---|---|
| Title | Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) |
| Official title | Locoregional Radiotherapy in Combination With Cetuximab in Inoperable Non-Small Cell Lung Cancer Stage III |
| Lead sponsor | Heidelberg University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | cetuximab |
| Enrollment | 30 |
| Start date | May 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Aug 1, 2010 |
| First posted | Jun 23, 2005 |
| Last update posted | Aug 5, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: